Tag : Business Insight

Public Health, Disease Prevention & Wellness

WuXi AppTec Earns Double “A” Rating for Climate & Water Leadership

PR Newswire
WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced that it has been recognized on the “A List” for...
Consulting & Advisory Services

NOBLE Launches NOBLE IQ to Boost National Security Readiness

PR Newswire
Tom Noble, CEO of Noble Supply and Logistics, LLC, today announced the launch of NOBLE IQ™, a new division delivering integrated safety, security, and operational readiness solutions...
Marketing, Advertising & Branding

Inter Miami CF, Lowe’s Renew Partnership at Miami Freedom Park

PR Newswire
Enhanced partnership expands Lowe’s presence, supporting the construction of Miami Freedom Park, player development, fan experience, and community programs Inter Miami CF today announced the renewal...
Digital Health, Technology & Innovation

Lightera Develops Fiber Temperature Feedback for Safer Laser Use

PR Newswire
BiOS – Hall D Booth #8430, Photonics West Hall F Booth #4505 — Lightera, a global leader in advanced specialty optical fiber solutions, announced today a new development...
Clinical Research, Pharma & Healthcare Financing

Syremis Therapeutics Raises $165M for Mental Health Drugs

Business Wire
Addressing major unmet needs in mental health with pharmacology rooted in emerging and clinically validated neuropsychiatric biology Lead program ST-905, a potent M1/M4 muscarinic agonist,...
Healthcare Infrastructure, Operations & Supply Chain

AtomVie Secures Supply Deal with Ionetix for Ac-225 Drugs

PR Newswire
AtomVie Global Radiopharma (AtomVie), a global radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in GMP manufacturing and clinical supply, is pleased to announce a...
Clinical Research, Pharma & Healthcare Financing

PharmAla Biotech Contracts UK CDMO for ALA-002 Production

GlobeNewswire
PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class...